StockNews.AI
NXGL
StockNews.AI
153 days

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

1. NEXGEL will report Q4 2024 results on March 24, 2025. 2. A conference call will follow the results announcement at 4:30 PM ET. 3. The company specializes in high-water-content hydrogel products for various applications. 4. NEXGEL has strategic relationships with major consumer healthcare firms. 5. Replay of the call will be available until April 3, 2025.

Earnings
-4.23%Current Return
VS
+0.77%S&P 500
$2.8403/19 09:05 AM EDTEvent Start
$2.7203/20 03:31 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

Upcoming financial results could indicate positive growth trends similar to past performances, potentially boosting investor confidence.

How important is it?

The earnings report will provide insights into NEXGEL's financial health, key for investors considering stock performance.

Why Short Term?

The financial results scheduled for March 24 can lead to immediate market reactions based on performance.

Related Companies

PFEJNJABT
Management will host a conference call at 4:30 p.m. ET on the same day LANGHORNE, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the fourth quarter and full year ended December 31, 2024, after the market closes on March 24, 2025. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day. Fourth Quarter and Full Year 2024 Financial Results Conference CallDate: March 24, 2025Time: 4:30 p.m. ETLive Call: 1-800-245-3047 (U.S. Toll Free) or 1-203-518-9765 (International)Webcast: Events and Presentations For interested individuals unable to join the conference call, a replay will be available through April 3, 2025 by dialing 1-844-512-2921(U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11158402. An archive of the webcast will also be available for 90 days. About NEXGEL, INC. NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies. Investor Contacts:Valter Pinto, Managing DirectorKCSA Strategic Communications212.896.1254Nexgel@KCSA.com

Related News